KZR
Kezar Life Sciences Inc
0.175$
+6.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.6% | +0.7% | -7.1% | +0.4% | -1,582.0% | – | -3.1% | -237.1% | – | +178.0% | -92.6% | – | |
| – | +65.0% | -51.5% | +6.6% | -10.2% | +3.2% | +3.8% | -16.0% | -12.9% | -11.8% | -23.8% | -59.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,260.3% | – | -141.3% | – | +165.0% | -73.3% | -569.3% | – | – | – | – | – | |
| – | -90.1% | -99.3% | -100.0% | – | – | -38.9% | -27.3% | -100.0% | – | – | – | – | |
| – | +40.7% | +50.1% | -26.8% | -40.1% | +97.0% | -1.3% | -42.1% | -17.1% | +37.9% | +228.5% | -97.0% | – | |
| – | – | – | – | – | – | – | – | +0.0% | +0.1% | +416.2% | – | – | |
| – | -88.7% | +37.2% | -100.0% | – | -100.0% | – | -2,874.5% | -2.7% | +2.8% | +413.9% | – | – | |
| – | – | – | -127.4% | – | – | +4.7% | -168.9% | – | – | +621.2% | -117.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.